AAAAAA
Results:
1-14
|
Results: 14
Authors:
Runge, VM
Citation: Vm. Runge, Allergic reactions to gadolinium chelates, AM J ROENTG, 177(4), 2001, pp. 944-944
Authors:
Knopp, MV
Lodemann, M
Kage, U
Runge, VM
Citation: Mv. Knopp et al., Use of MR-contrast agents outside of their labeled indication, RADIOLOGE, 41(3), 2001, pp. 296-302
Authors:
Runge, VM
Armstrong, MR
Barr, RG
Berger, BL
Czervionke, LF
Gonzalez, CF
Halford, HH
Kanal, E
Kuhn, MJ
Levin, JM
Low, RN
Tanenbaum, LN
Wang, AM
Wong, W
Yuh, WTC
Zoarski, GH
Citation: Vm. Runge et al., A clinical comparison of the safety and efficacy of MultiHance (gadobenatedimeglumine) and Omniscan (gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology, INV RADIOL, 36(2), 2001, pp. 65-71
Authors:
Runge, VM
Citation: Vm. Runge, A review of contrast media research in 1999-2000 (vol 36, pg 123, 2000), INV RADIOL, 36(2), 2001, pp. 122-130
Authors:
Runge, VM
Citation: Vm. Runge, Safety of magnetic resonance contrast agents, MAGNETIC RESONANCE PROCEDURES: HEALTH EFFECTS AND SAFETY, 2001, pp. 241-259
Authors:
Runge, VM
Kenney, CM
Citation: Vm. Runge et Cm. Kenney, Phase II double-blind, dose-ranging clinical evaluation of gadobenate dimeglumine in focal liver lesions: With analysis of liver and kidney signal change on early and delayed imaging, J MAGN R I, 11(6), 2000, pp. 655-664
Authors:
Marinelli, ER
Neubeck, R
Song, B
Wagler, T
Ranganathan, RS
Sukumaran, K
Wedeking, PW
Nunn, A
Runge, VM
Tweedle, MF
Citation: Er. Marinelli et al., Synthesis, characterization, and imaging performance of a new class of macrocyclic hepatobiliary MR contrast agents, INV RADIOL, 35(1), 2000, pp. 8-24
Authors:
Saini, S
Sharma, R
Baron, RL
Turner, DA
Ros, PR
Hahn, PF
Small, WC
Delange, EE
Stillman, AE
Edelman, RR
Runge, VM
Outwater, EK
Citation: S. Saini et al., Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 forliver MR imaging, CLIN RADIOL, 55(9), 2000, pp. 690-695
Authors:
Sharma, R
Saini, S
Ros, PR
Hahn, PF
Small, WC
de Lange, EE
Stillman, AE
Edelman, RR
Runge, VM
Outwater, EK
Morris, M
Lucas, N
Citation: R. Sharma et al., Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: Phase II clinical trial data, J MAGN R I, 9(2), 1999, pp. 291-294
Authors:
Taylor, JS
Tofts, PS
Phil, D
Port, R
Evelhoch, JL
Knopp, M
Reddick, WE
Runge, VM
Mayr, N
Citation: Js. Taylor et al., MR imaging of tumor microcirculation: Promise for the new millenium, J MAGN R I, 10(6), 1999, pp. 903-907
Authors:
Runge, VM
Citation: Vm. Runge, Changes in the approval process for contrast media, J MAGN R I, 10(3), 1999, pp. 485-488
Authors:
Runge, VM
Knopp, MV
Citation: Vm. Runge et Mv. Knopp, Off-label use and reimbursement of contrast media in MR, J MAGN R I, 10(3), 1999, pp. 489-495
Authors:
Small, WC
DeSimone-Macchi, D
Parker, JR
Sukerkar, A
Hahn, PF
Rubin, DL
Zelch, JV
Kuhlman, JE
Outwater, EK
Weinreb, JC
Brown, JJ
de Lange, EE
Woodward, PJ
Arildsen, R
Foster, GS
Runge, VM
Aisen, AM
Muroff, LR
Thoeni, RF
Parisky, YR
Tanenbaum, LN
Totterman, S
Herfkens, RJ
Knudsen, J
Laster, RE
Duerinckx, A
Stillman, AE
Spritzer, CE
Saini, S
Rofsky, NM
Bernardino, ME
Citation: Wc. Small et al., A multisite Phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis, J MAGN R I, 10(1), 1999, pp. 15-24
Authors:
Runge, VM
Citation: Vm. Runge, Contrast media research, INV RADIOL, 34(12), 1999, pp. 785-790
Risultati:
1-14
|